Evidence map›Paper›PMID 41247403›Full record

ArticleMikrochimica acta2025

A QR code-assisted paper-based analytical device for rapid and reliable detection of dehydroepiandrosterone.

Emine Guler Celik

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Emine Guler CelikDepartment of Bioengineering, Faculty of Engineering, Ege University, Izmir, 35100, Turkey. emine.guler.celik@ege.edu.tr.ORCID 0000-0003-2381-9775

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

QR code-assisted paper-based analytical devices (QR-PAD) are presented for the rapid detection of dehydroepiandrosterone (DHEA), a critical biomarker associated with diverse pathological and physiological conditions. The QR-PAD platform comprises two folded layers: an acetate sheet for QR code readout and a nitrocellulose (NC) membrane as the testing surface. The system enables standardized qualitative analysis through QR code decoding and quantitative analysis via colorimetric evaluation of test spots. Importantly, the QR-PAD successfully detected DHEA in synthetic serum samples without interference from testosterone, cholesterol, or bovine serum albumin (BSA). Overall, this dual-mode QR-PAD demonstrates both qualitative and quantitative detection capabilities, merging the advantages of QR technology and paper substrates to advance practical, portable, and reliable diagnostic solutions.

Indexed as

DehydroepiandrosteronePaperAnimalsCattleCollodionColorimetryHumansLimit of DetectionSerum Albumin, BovineCollodionDehydroepiandrosteroneSerum Albumin, BovineBiomarker detectionColorimetric detectionDehydroepiandrosteronePaper-based analytical devicePoint-of-Care diagnosticsQR-based tests

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.